Cargando…

Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: A cross-sectional study

Background: An international consensus list of potentially clinically significant drug-drug interactions (DDIs) in older people has been recently validated. Our objective was to describe the prevalence and characteristics of drug combinations potentially causing clinically significant DDIs identifie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Očovská, Zuzana, Maříková, Martina, Vlček, Jiří
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932507/ https://www.ncbi.nlm.nih.gov/pubmed/36817138 http://dx.doi.org/10.3389/fphar.2023.1088900

Ejemplares similares

Drug-Related Hospital Admissions via the Department of Emergency Medicine: A Cross-Sectional Study From the Czech Republic
por: Očovská, Zuzana, et al.
Publicado: (2022)

Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study
por: Zhao, Mei, et al.
Publicado: (2022)

Potentially Hazardous Drug-Drug Interactions Associated With Oral Antineoplastic Agents Prescribed in Chinese Tertiary Care Teaching Hospital Settings: A Multicenter Cross-Sectional Study
por: Wang, Haitao, et al.
Publicado: (2022)

The Challenge of Potential Drug–Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China
por: Xia, Huan, et al.
Publicado: (2020)

Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
por: Létinier, Louis, et al.
Publicado: (2019)

A Minimal Information Model for Potential Drug-Drug Interactions
por: Hochheiser, Harry, et al.
Publicado: (2021)

Potential drug interactions in drug therapy prescribed for older adults at hospital discharge: cross-sectional study
por: Dias, Bianca Menezes, et al.
Publicado: (2019)

Potentially inappropriate medication including drug-drug interaction and the risk of frequent falling, hospital admission, and death in older adults - results of a large cohort study (getABI)
por: Reinhild Haerig, Theresa, et al.
Publicado: (2023)

Potential drug–drug interactions among elderly patients admitted to medical ward of Ayder Referral Hospital, Northern Ethiopia: a cross sectional study
por: Teka, Fantaye, et al.
Publicado: (2016)

Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region
por: Burato, Sofia, et al.
Publicado: (2021)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Severe Potential Drug-Drug Interactions and the Increased Length of Stay of Children in Intensive Care Unit
por: Lima, Elisangela da Costa, et al.
Publicado: (2020)

Potential drug-drug interaction of olverembatinib (HQP1351) using physiologically based pharmacokinetic models
por: Yu, Zhiheng, et al.
Publicado: (2022)

Opioid Drug-Drug-Drug Interactions and Unintentional Traumatic Injury: Screening to Detect Three-Way Drug Interaction Signals
por: Acton, Emily K., et al.
Publicado: (2022)

Assessing Drug-Drug Interaction Potential among Patients Admitted to Surgery Departments in Three Palestinian Hospitals
por: Rabba, Abdullah K., et al.
Publicado: (2020)

Editorial: Evidence for Assessing Drug Safety and Drug Use in Older People
por: Lopes, Luciane Cruz, et al.
Publicado: (2022)

Safety, Pharmacokinetics, and Drug-Drug Interaction Potential of Intravenous Durlobactam, a β-Lactamase Inhibitor, in Healthy Subjects
por: Lickliter, Jason D., et al.
Publicado: (2020)

Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety
por: Noor, Sidra, et al.
Publicado: (2019)

Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications
por: Stader, Felix, et al.
Publicado: (2018)

Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
por: Hecker, Michael, et al.
Publicado: (2022)

Drug-Drug Interactions at Organic Cation Transporter 1
por: Zhou, Shiwei, et al.
Publicado: (2021)

Polypharmacy and Potential Drug–Drug Interactions in Home-Dwelling Older People – A Cross-Sectional Study
por: Hermann, Monica, et al.
Publicado: (2021)

Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions
por: Mazzari, Andre L. D. A., et al.
Publicado: (2014)

Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis
por: Stemkens, Ralf, et al.
Publicado: (2023)

Potentially Inappropriate Prescribing and Potential Clinically Significant Drug–Drug Interactions in Older Outpatients: Is There Any Association?
por: Cvetković, Zorica, et al.
Publicado: (2019)

Potential Metabolic Drug–Drug Interaction of Citrus aurantium L. (Rutaceae) Evaluating by Its Effect on 3 CYP450
por: Zhou, Lu, et al.
Publicado: (2018)

Prevalence of Potential Drug-Drug Interactions Among Hypertensive Pregnant Women Admitted to a Tertiary Care Hospital
por: Ragam, Akshitha S, et al.
Publicado: (2023)

Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects
por: Mallikaarjun, Suresh, et al.
Publicado: (2016)

Prevalence and Clinical Significance of Drug–Drug and Drug–Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece
por: Spanakis, Marios, et al.
Publicado: (2021)

Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients
por: Arcoraci, Vincenzo, et al.
Publicado: (2021)

Evaluation of drug interaction potential of Labisia pumila (Kacip Fatimah) and its constituents
por: Manda, Vamshi K., et al.
Publicado: (2014)

Corrigendum: Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions
por: Mazzari, Andre L. D. A., et al.
Publicado: (2015)

Mass Balance and Drug Interaction Potential of Intravenous Eravacycline Administered to Healthy Subjects
por: Newman, Joseph V., et al.
Publicado: (2019)

Application of Physiologically Based Pharmacokinetic Modeling to Evaluate the Drug–Drug and Drug–Disease Interactions of Apatinib
por: Liu, Hongrui, et al.
Publicado: (2021)

Prediction of the Drug–Drug Interaction Types with the Unified Embedding Features from Drug Similarity Networks
por: Yan, Xiao-Ying, et al.
Publicado: (2021)

Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic
por: Barceló-Vidal, J., et al.
Publicado: (2022)

Knowledge, Attitude and Practice of Hospital Pharmacists in Central China Towards Adverse Drug Reaction Reporting: A Multicenter Cross‐Sectional Study
por: Hu, Wen, et al.
Publicado: (2022)

Potential Drug-drug Interaction among the Patients Admitted in Intensive Care Units of a Tertiary Care Centre: A Descriptive Cross-sectional Study
por: Ghimire, Rakesh, et al.
Publicado: (2022)

Revealing the dynamic landscape of drug-drug interactions through network analysis
por: Jeong, Eugene, et al.
Publicado: (2023)

Editorial: Pharmacokinetic Evaluation and Modeling of Clinically Significant Drug Metabolites
por: Mircioiu, Constantin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nkniclhjhcnhgb1g9399o47ag8